NCT07538817

Brief Summary

Oxygen administration is essential in the perioperative period to prevent hypoxia; however, excessive oxygen may cause hyperoxia and related complications. While pulse oximetry is effective in detecting hypoxemia, it is insufficient for identifying hyperoxia when SpO₂ exceeds 97%, often necessitating invasive arterial blood gas analysis. The Oxygen Reserve Index (ORI) is a noninvasive, real-time monitoring parameter reflecting moderate hyperoxic ranges (PaO₂ 100-200 mmHg) and provides early warning of oxygenation changes before SpO₂ alterations occur. Combined use of ORI and pulse oximetry may enable optimal oxygen titration and prevention of both hypoxemia and hyperoxemia. Laparoscopic nephrectomy is widely performed due to its clinical advantages. In our practice, low and normal fresh gas flow anesthesia are commonly used. Low-flow anesthesia offers benefits such as preservation of heat and humidity, reduced cost, and improved airway physiology. This study aims to determine optimal oxygenation levels during laparoscopic nephrectomy under low and normal fresh gas flow conditions using ORI monitoring.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
3mo left

Started Apr 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Apr 2026Aug 2026

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2026

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

April 13, 2026

Last Update Submit

April 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Early detection of hypoxia and hyperoxia in laparoscopic nephrectomy cases with low and normal flow anesthesia using ORI monitoring.

    Perioperative period(approximately 3-6 hours

Secondary Outcomes (1)

  • The effect of lateral decubitus position on oxygenation in laparoscopic nephrectomies

    Perioperative period(approximately 3-6 hours)

Study Arms (2)

low-flow anesthesia

0,5 lt/min

normal flow anesthesia

2 lt/min

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ages 18-75, ASA I,II, elective surgery laparoscopic nephrectomy

You may qualify if:

  • Ages 18-75
  • ASA I,II
  • elective surgery laparoscopic nephrectomy

You may not qualify if:

  • ASA III,IV,V
  • BMI \> 35
  • Those with serious respiratory disease
  • Medications that cause peripheral circulation disorders
  • Patients who started with laparoscopic surgery and then underwent open surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

July 20, 2026

Study Completion (Estimated)

August 20, 2026

Last Updated

April 20, 2026

Record last verified: 2026-04